$ARKK breaking out and going parabolic? That's not exactly the consensus call for 2027. Most desks are still skeptical on Cathie's flagship after years of underperformance and heavy redemptions. But if we get a sustained AI infrastructure rally, falling rates, and a rotation back into growth—especially disruptive tech—this could be one of the better contrarian setups. The portfolio's loaded with high-beta names in genomics, robotics, and AI. It's a crowded short, which means any squeeze could get violent. Not saying it happens, but the asymmetry is there if the macro backdrop flips. Worth watching positioning into year-end.